Detalhe da pesquisa
1.
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia.
Blood
; 141(9): 996-1006, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108341
2.
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
Int J Cancer
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38703351
3.
Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention.
BMC Med Inform Decis Mak
; 24(1): 32, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308286
4.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
5.
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
BMC Cancer
; 23(1): 205, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870947
6.
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.
Invest New Drugs
; 40(4): 762-772, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467243
7.
Core values of patients with advanced cancer considering participation in an early-phase clinical trial: a qualitative study.
Support Care Cancer
; 30(9): 7605-7613, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35676342
8.
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
Br J Cancer
; 125(1): 28-37, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941878
9.
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours.
Br J Cancer
; 124(4): 728-735, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230210
10.
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors.
Future Oncol
; 17(21): 2747-2758, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849298
11.
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
Invest New Drugs
; 38(4): 1117-1128, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31667659
12.
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
Invest New Drugs
; 38(4): 1096-1107, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637669
13.
A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours.
Br J Cancer
; 120(3): 286-293, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30585255
14.
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.
Gynecol Oncol
; 153(1): 127-134, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30686551
15.
Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).
BMC Palliat Care
; 18(1): 106, 2019 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31783851
16.
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer.
Invest New Drugs
; 36(5): 828-835, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313279
17.
Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.
Psychooncology
; 27(1): 163-170, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28665008
18.
Self-reported quality of life and hope in phase-I trial participants: An observational prospective cohort study.
Eur J Cancer Care (Engl)
; 27(6): e12908, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30179287
19.
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
Oncologist
; 22(1): 33-40, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662884
20.
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 32(4): 670-81, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652201